Sign up to save your podcasts
Or
Share Healthcare Industry in Flux: Trends in M&A, Technology, and Shifting Care Models
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Healthcare Industry in Flux: Trends in M&A, Technology, and Shifting Care Models
The health care industry has seen significant movement over the past 48 hours, highlighting a period of rapid change and cautious optimism among industry leaders. Market activity has been robust. Notably, American Healthcare REIT announced Q1 2025 financial results and raised its full-year guidance, citing a pipeline of over 300 million dollars in new acquisitions. This signals strong investor confidence and a competitive acquisition environment, with health care real estate remaining an attractive asset class for expansion and investment.
Mergers and acquisitions are at the forefront of strategic growth, with over 80 percent of core health care providers and 96 percent of payers projecting an increase in deal activity for 2025. The industry expects more consolidations as hospitals and health systems seek stability amidst persistent staffing shortages and financial headwinds, such as declining federal support. Life sciences executives are also generally positive, with 70 percent anticipating more transactions, especially as smaller entities look for partners to weather rising costs and regulatory complexity.
Workforce dynamics are shifting. The ambulatory care sector now accounts for 48 percent of all health care hires, reflecting a broader trend of care delivery moving away from traditional acute settings toward outpatient and digital-first models. Consumer preferences for convenience, digital access, and cost transparency are accelerating this shift, driving investments in health services and technology platforms.
Regulatory uncertainty remains a concern due to ongoing shifts in federal administration and potential policy updates, but investment in healthcare software, data analytics, and specialty pharmacies continues to grow. These technology-driven segments are expected to see revenue pools rise at an annual rate of 8 percent through 2028. In particular, new therapies and specialty drugs are fueling the growth of specialty pharmacy services.
Overall, health care leaders are responding to challenges by pursuing strategic partnerships, investing in technology, and reallocating resources to faster-growing and more resilient segments. Compared to previous reporting earlier this year, there is greater emphasis on non-acute care, technology integration, and M and A activity, marking a definite shift in priorities as the industry adapts to economic and regulatory pressures while striving to meet evolving patient expectations.
Mergers and acquisitions are at the forefront of strategic growth, with over 80 percent of core health care providers and 96 percent of payers projecting an increase in deal activity for 2025. The industry expects more consolidations as hospitals and health systems seek stability amidst persistent staffing shortages and financial headwinds, such as declining federal support. Life sciences executives are also generally positive, with 70 percent anticipating more transactions, especially as smaller entities look for partners to weather rising costs and regulatory complexity.
Workforce dynamics are shifting. The ambulatory care sector now accounts for 48 percent of all health care hires, reflecting a broader trend of care delivery moving away from traditional acute settings toward outpatient and digital-first models. Consumer preferences for convenience, digital access, and cost transparency are accelerating this shift, driving investments in health services and technology platforms.
Regulatory uncertainty remains a concern due to ongoing shifts in federal administration and potential policy updates, but investment in healthcare software, data analytics, and specialty pharmacies continues to grow. These technology-driven segments are expected to see revenue pools rise at an annual rate of 8 percent through 2028. In particular, new therapies and specialty drugs are fueling the growth of specialty pharmacy services.
Overall, health care leaders are responding to challenges by pursuing strategic partnerships, investing in technology, and reallocating resources to faster-growing and more resilient segments. Compared to previous reporting earlier this year, there is greater emphasis on non-acute care, technology integration, and M and A activity, marking a definite shift in priorities as the industry adapts to economic and regulatory pressures while striving to meet evolving patient expectations.
View all episodes
By Quiet. PleaseThe health care industry has seen significant movement over the past 48 hours, highlighting a period of rapid change and cautious optimism among industry leaders. Market activity has been robust. Notably, American Healthcare REIT announced Q1 2025 financial results and raised its full-year guidance, citing a pipeline of over 300 million dollars in new acquisitions. This signals strong investor confidence and a competitive acquisition environment, with health care real estate remaining an attractive asset class for expansion and investment.
Mergers and acquisitions are at the forefront of strategic growth, with over 80 percent of core health care providers and 96 percent of payers projecting an increase in deal activity for 2025. The industry expects more consolidations as hospitals and health systems seek stability amidst persistent staffing shortages and financial headwinds, such as declining federal support. Life sciences executives are also generally positive, with 70 percent anticipating more transactions, especially as smaller entities look for partners to weather rising costs and regulatory complexity.
Workforce dynamics are shifting. The ambulatory care sector now accounts for 48 percent of all health care hires, reflecting a broader trend of care delivery moving away from traditional acute settings toward outpatient and digital-first models. Consumer preferences for convenience, digital access, and cost transparency are accelerating this shift, driving investments in health services and technology platforms.
Regulatory uncertainty remains a concern due to ongoing shifts in federal administration and potential policy updates, but investment in healthcare software, data analytics, and specialty pharmacies continues to grow. These technology-driven segments are expected to see revenue pools rise at an annual rate of 8 percent through 2028. In particular, new therapies and specialty drugs are fueling the growth of specialty pharmacy services.
Overall, health care leaders are responding to challenges by pursuing strategic partnerships, investing in technology, and reallocating resources to faster-growing and more resilient segments. Compared to previous reporting earlier this year, there is greater emphasis on non-acute care, technology integration, and M and A activity, marking a definite shift in priorities as the industry adapts to economic and regulatory pressures while striving to meet evolving patient expectations.
Mergers and acquisitions are at the forefront of strategic growth, with over 80 percent of core health care providers and 96 percent of payers projecting an increase in deal activity for 2025. The industry expects more consolidations as hospitals and health systems seek stability amidst persistent staffing shortages and financial headwinds, such as declining federal support. Life sciences executives are also generally positive, with 70 percent anticipating more transactions, especially as smaller entities look for partners to weather rising costs and regulatory complexity.
Workforce dynamics are shifting. The ambulatory care sector now accounts for 48 percent of all health care hires, reflecting a broader trend of care delivery moving away from traditional acute settings toward outpatient and digital-first models. Consumer preferences for convenience, digital access, and cost transparency are accelerating this shift, driving investments in health services and technology platforms.
Regulatory uncertainty remains a concern due to ongoing shifts in federal administration and potential policy updates, but investment in healthcare software, data analytics, and specialty pharmacies continues to grow. These technology-driven segments are expected to see revenue pools rise at an annual rate of 8 percent through 2028. In particular, new therapies and specialty drugs are fueling the growth of specialty pharmacy services.
Overall, health care leaders are responding to challenges by pursuing strategic partnerships, investing in technology, and reallocating resources to faster-growing and more resilient segments. Compared to previous reporting earlier this year, there is greater emphasis on non-acute care, technology integration, and M and A activity, marking a definite shift in priorities as the industry adapts to economic and regulatory pressures while striving to meet evolving patient expectations.